Thomas Decaens
Centre National de la Recherche Scientifique(FR)Centre National de la Recherche Scientifique(FR)Inserm(FR)Inserm(FR)Centre Hospitalier Universitaire de Grenoble(FR)Immunité et Cancer(FR)Grenoble Institute of Neurosciences(FR)Institut de Biosciences et Biotechnologies(FR)Institut pour l'avancée des biosciences(FR)Hôpital Albert Michallon(FR)Université Grenoble Alpes(FR)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, Hepatitis C virus research, Organ Transplantation Techniques and Outcomes
Most-Cited Works
- → NASH limits anti-tumour surveillance in immunotherapy-treated HCC(2021)1,186 cited
- → Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria(2012)931 cited
- → Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study(2013)766 cited
- → Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study(2013)593 cited
- → Apc Tumor Suppressor Gene Is the “Zonation-Keeper” of Mouse Liver(2006)522 cited
- → Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial